Compound class:
Synthetic organic
Comment: Compound 3a has been reported as an inverse agonist of GPR55 [1]. It exhibits antiproliferative activity against breast cancer cells in vitro (e.g. MDA-MB-231 IC50 2700 nM, MCF10A IC50 3700 nM).
|
|
Selectivity at GPCRs | ||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|